Silo Pharma, Inc.

SILO · Nasdaq · SIC 2834: Pharmaceutical Preparations
175
SEC Filings

Business Summary

Overview We are a developmental stage biopharmaceutical and cryptocurrency company. Our therapeutics focus is on developing novel therapeutics that address underserved conditions including PTSD, stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. We are focused on developing novel therapies that include conventional drugs and psychedelic formulations. The Companys lead program, SPC-15, is an intranasal drug targeting PTSD and stress-induced anxiety disorder...

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSILOdiscussed_in_filing Cybersecurity
topic_mentionSILOdiscussed_in_filing Trusted Computing
topic_mentionSILOdiscussed_in_filing Blockchain & Crypto
topic_mentionSILOdiscussed_in_filing Regulation
topic_mentionSILOdiscussed_in_filing Healthcare & Bio
topic_mentionSILOdiscussed_in_filing Sovereign & Government
topic_mentionSILOdiscussed_in_filing Cybersecurity
topic_mentionSILOdiscussed_in_filing Trusted Computing
topic_mentionSILOdiscussed_in_filing Blockchain & Crypto
topic_mentionSILOdiscussed_in_filing Regulation
topic_mentionSILOdiscussed_in_filing Healthcare & Bio
topic_mentionSILOdiscussed_in_filing Sovereign & Government
topic_mentionSILOdiscussed_in_filing Cybersecurity
topic_mentionSILOdiscussed_in_filing Trusted Computing
topic_mentionSILOdiscussed_in_filing Blockchain & Crypto
topic_mentionSILOdiscussed_in_filing Regulation
topic_mentionSILOdiscussed_in_filing Healthcare & Bio
topic_mentionSILOdiscussed_in_filing Sovereign & Government
topic_mentionSILOdiscussed_in_filing Cybersecurity
topic_mentionSILOdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001213900-26-035576EDGAR88K words
2025-03-282024-12-310001013762-25-004139EDGAR
2024-03-252023-12-310001213900-24-025615EDGAR
2023-03-242022-12-310001213900-23-022813EDGAR
2022-03-282021-12-310001213900-22-015521EDGAR
2021-03-292020-12-310001213900-21-018270EDGAR
2020-03-202019-12-310001213900-20-007000EDGAR
2019-04-042018-12-310001213900-19-005789EDGAR
2018-04-022017-12-310001213900-18-003903EDGAR
2017-03-312016-12-310001213900-17-003182EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001213900-25-110006EDGAR38K words
2025-08-132025-06-300001213900-25-075693EDGAR
2025-05-092025-03-310001213900-25-041519EDGAR
2024-11-122024-09-300001213900-24-096841EDGAR
2024-08-132024-06-300001213900-24-068296EDGAR
2024-05-132024-03-310001213900-24-042299EDGAR
2023-11-132023-09-300001213900-23-086214EDGAR
2023-08-112023-06-300001213900-23-066300EDGAR
2023-05-122023-03-310001213900-23-039078EDGAR
2022-11-102022-09-300001213900-22-071252EDGAR
2022-08-012022-06-300001213900-22-043390EDGAR
2022-05-132022-03-310001213900-22-026450EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001213900-26-039352EDGAR3K words
2026-02-230001213900-26-019384EDGAR
2025-12-290001213900-25-125838EDGAR
2025-10-240001213900-25-102222EDGAR
2025-10-010001213900-25-094711EDGAR
2025-08-050001213900-25-072062EDGAR
2025-07-290001213900-25-068740EDGAR
2025-07-100001213900-25-062805EDGAR
2025-07-030001213900-25-061531EDGAR
2025-05-160001213900-25-044913EDGAR

175 total filings indexed. 143 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001514183
TickerSILO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 3ace9db0f3ec24e03c1b330b73016dde2c4f3c2de070fd84dbf4443de4b63c76
parent: d17eedb6a0157fd6dffb13dbd75a6f1cd9f1b75437331842e0ed41548ab1cedd
content hash: 8116b9c35f3e60fd09886544b9a61f6897bebf1aa5272cd4399ef2ae1758afb8
signed: 2026-04-13T04:47:26.744Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf